Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 117 of 1,261
  1. US 11987586

    Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists

    Takeda Pharmaceutical Company Limited · Granted May 21, 2024 · Expires May 16, 2044

    granted
  2. US 11986537

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  3. US 11986534

    Treatment of anthrax with pegylated capsule-degrading enzyme

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted May 21, 2024 · Expires May 16, 2044

    granted
  4. US 11986471

    Compounds and methods of use

    Tango Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  5. US 11986511

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  6. US 11986454

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  7. US 11986455

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  8. US 11986481

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  9. US 11986515

    Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)

    REGENXBIO INC. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  10. US 11981921

    TIL expansion processes using specific cytokine combinations and/or AKTi treatment

    Iovance Biotherapeutics, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  11. US 11980602

    Cannabinoid prodrug compounds

    Firstlight Pharmaceuticals LLC · Granted May 14, 2024 · Expires May 9, 2044

    granted
  12. US 11981707

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2024 · Expires May 9, 2044

    granted
  13. US 11981740

    BAFF-R antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  14. US 11981741

    Humanized anti-CD45 antibodies

    Actinium Phamaceuticals, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  15. US 11980645

    Bile acids and use in disease treatment

    The Regents of the University of California · Granted May 14, 2024 · Expires May 9, 2044

    granted
  16. US 11980634

    Method of reconstituting liposomal annamycin

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  17. US 11981752

    Tumor associated monocyte/macrophage binding peptide and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted May 14, 2024 · Expires May 9, 2044

    granted
  18. US 11981760

    Therapeutic hydrogels and contact lens for corneal melting

    The Regents of the University of Colorado, a Body Corporate · Granted May 14, 2024 · Expires May 9, 2044

    granted
  19. US 11982672

    Methods

    AUTOLUS LIMITED · Granted May 14, 2024 · Expires May 9, 2044

    granted
  20. US 11981736

    Antibodies specific to glycosylated PD-1 and methods of use thereof

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  21. US 11982673

    Methods

    AUTOLUS LIMITED · Granted May 14, 2024 · Expires May 9, 2044

    granted
  22. US 11981967

    Engineering AAV

    Sangamo Therapeutics, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  23. US 11981730

    Anti-CXCL13 antibodies and methods of using the same

    VACCINEX, INC. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  24. US 11981944

    Immunogenic arginase peptides

    IO Biotech ApS · Granted May 14, 2024 · Expires May 9, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.